Inactive/Delisted stock

CERo Therapeutics Stock (NASDAQ:CEROW)


FinancialsChart

Previous Close

$0.01

52W Range

$0.01 - $0.01

50D Avg

-

200D Avg

-

Market Cap

$405.23K

Avg Vol (3M)

-

Beta

-0.46

Div Yield

-

CEROW Company Profile


CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell and myeloid tumors. The company is based in South San Francisco, California.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

8

IPO Date

-

Website

CEROW Performance


CEROW Financial Summary


Dec 22Dec 21
Revenue--
Operating Income$-11.97M$-11.62M
Net Income$-11.83M$-10.63M
EBITDA$-10.90M$-10.88M
Basic EPS--
Diluted EPS--

Fiscal year ends in Dec 22 | Currency in USD